Growth Metrics

DBV Technologies (DBVT) Net Margin (2014 - 2026)

DBV Technologies (DBVT) reported Net Margin of 5288.89% for Q1 2026, down 190139.0% year-over-year from N/an in Q1 2025, and up 23.9% on a QoQ basis from 6950.23% in Q4 2025.

DBV Technologies (DBVT) has 11 years of Net Margin data on file, last reported at 5288.89% in Q1 2026.

  • Quarterly Net Margin fell 190139.0% year-over-year to 5288.89% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2895.37% (up 31211.0% YoY) and the FY2025 annual result came in at 2607.29%, up 13706.0% from the prior year.
  • Net Margin advanced to 5288.89% in Q1 2026 per DBVT's latest filing, from 6950.23% in the prior quarter.
  • Across five years, Net Margin topped out at 3009.28% in Q4 2022 and bottomed at 6950.23% in Q4 2025.
  • The 5-year median for Net Margin is 1506.8% (2022), against an average of 2037.39%.
  • The widest annual swing landed in 2022, when Net Margin surged 347558 bps; it then slumped 437787 bps in 2024.
  • Tracing DBVT's Net Margin over 5 years: stood at 3009.28% in 2022, then tumbled by 104 bps to 126.04% in 2023, then slumped by 3473 bps to 4503.91% in 2024, then tumbled by 54 bps to 6950.23% in 2025, then gained by 24 bps to 5288.89% in 2026.
  • Per Business Quant, the three latest DBVT Net Margin figures stand at 5288.89% (Q1 2026), 6950.23% (Q4 2025), and 1195.53% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.82%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 34.53%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 20.17%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 17.65%
10 DBV Technologies 8.00 Bn 7.77 Bn -3.90 Mn -5,288.89%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -5,288.89%
Dec 31, 2025 -6,950.23%
Sep 30, 2025 -1,195.53%
Jun 30, 2025 -2,858.36%
Mar 31, 2025 -3,387.50%
Dec 31, 2024 -4,503.91%
Sep 30, 2024 -2,839.74%
Jun 30, 2024 -2,852.37%
Mar 31, 2024 -1,943.50%
Dec 31, 2023 -126.04%
Sep 30, 2023 -705.56%
Jun 30, 2023 -1,059.57%
Mar 31, 2023 -937.15%
Dec 31, 2022 3,009.28%
Sep 30, 2022 -833.51%
Jun 30, 2022 -1,506.80%
Mar 31, 2022 -656.17%
Dec 31, 2021 -466.30%
Sep 30, 2021 -1,816.55%
Jun 30, 2021 -2,060.08%
Mar 31, 2021 -1,001.33%
Dec 31, 2020 3,257.84%
Sep 30, 2020 -744.47%
Mar 31, 2020 -866.80%
Sep 30, 2019 -1,190.75%
Dec 31, 2018 493.10%
Sep 30, 2018 -1,458.28%
Dec 31, 2015 -470.57%
Jun 30, 2015 -13,250.00%
Dec 31, 2014 -454.14%
Jun 30, 2014 -11,362.63%